Shopping Cart
Remove All
Your shopping cart is currently empty
Laventatug is a humanized monoclonal antibody targeting human SLC39A6. By specifically binding to SLC39A6, it disrupts the transport process of zinc ions within cells, thereby exhibiting antitumor activity. Laventatug holds potential for cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Laventatug is a humanized monoclonal antibody targeting human SLC39A6. By specifically binding to SLC39A6, it disrupts the transport process of zinc ions within cells, thereby exhibiting antitumor activity. Laventatug holds potential for cancer research. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | SLC39A6 |
| Cas No. | 3009829-91-5 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.